Keyword Suggestion
Domain Informations
Nabriva.com lookup results from whois.corporatedomains.com server:
- Domain created: 2006-01-23T21:20:36Z
- Domain updated: 2024-01-19T06:07:19Z
- Domain expires: 2025-01-23T21:20:36Z 0 Years, 133 Days left
- Website age: 18 Years, 231 Days
- Registrar Domain ID: 324987402_DOMAIN_COM-VRSN
- Registrar Url: http://cscdbs.com
- Registrar WHOIS Server: whois.corporatedomains.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 8887802723
- Name server:
- DNS1.CSCDNS.NET
- DNS2.CSCDNS.NET
Network
- inetnum : 52.145.0.0 - 52.191.255.255
- name : MSFT
- handle : NET-52-145-0-0-1
- status : Direct Allocation
- created : 1998-07-10
- changed : 2024-03-18
- desc : To report suspected security issues specific to traffic emanating from Microsoft online services, including the distribution of malicious content or other illicit or illegal material through a Microsoft online service, please submit reports to:,* https://cert.microsoft.com.,For SPAM and other abuse issues, such as Microsoft Accounts, please contact:,* [email protected].,To report security vulnerabilities in Microsoft products and services, please contact:,* [email protected].,For legal and law enforcement-related requests, please contact:,* [email protected],For routing, peering or DNS issues, please,contact:,* [email protected]
Owner
- organization : Microsoft Corporation
- handle : MSFT
- address : Array,Redmond,WA,98052,US
Technical support
- handle : IPHOS5-ARIN
- name : IPHostmaster, IPHostmaster
- phone : +1-425-538-6637
- email : [email protected]
Abuse
- handle : MAC74-ARIN
- name : Microsoft Abuse Contact
- phone : +1-425-882-8080
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 286730 |
namecheap.com | 101387 |
networksolutions.com | 69118 |
tucows.com | 52617 |
publicdomainregistry.com | 39120 |
whois.godaddy.com | 32793 |
enomdomains.com | 23825 |
namesilo.com | 21429 |
domains.google.com | 21384 |
cloudflare.com | 20573 |
gmo.jp | 18110 |
name.com | 17601 |
fastdomain.com | 14708 |
register.com | 13495 |
net.cn | 12481 |
ionos.com | 12416 |
ovh.com | 12416 |
gandi.net | 12305 |
registrar.amazon.com | 12111 |
Host Informations
- IP address: 52.176.165.69
- Location: Des Moines United States
- Latitude: 41.6006
- Longitude: -93.6112
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 52.176.165.69)
Spam Check (IP: 52.176.165.69)
Email address with nabriva.com
2. [email protected]
3. [email protected]
4. [email protected]
5. [email protected]
6. [email protected]
7. [email protected]
8. [email protected]
9. [email protected]
Recent Searched Sites
› Uk.appewa.com (15 seconds ago) / US
› Sancogrup.ro (8 seconds ago) / RO
› Capeindustrialflooring.co.za (3 seconds ago) / ZA
› Dewporn.com (51 seconds ago) / US
› Link22.world (19 seconds ago) / IR
› Crystalherbs.com (43 seconds ago) / US
› Elia.com.mt (25 seconds ago) / US
› Gtamerica.us (15 seconds ago) / GB
› Emoji.supply (1 mins ago) / US
› Kolmelhior.ru (8 seconds ago) / RU
› Nabriva.com (0 seconds ago) / US
› Rovelver.com (7 seconds ago) / US
› Media.clubrural.com (57 seconds ago) / UA
› Carolineamiguet.com (0 seconds ago) / US
› Jmana.net (6 seconds ago) / US
› Dancingyaksf.com (4 seconds ago) / US
› Flynumber.com (4 seconds ago) / US
› Ayushcare.in (4 seconds ago) / CA
› Hvizdateam.com (8 seconds ago) / US
› Headlinespaperd.blogspot.com (14 seconds ago) / US
Websites Listing
We found Websites Listing below when search with nabriva.com on Search Engine
Nabriva Announces Availability of XENLETA® (lefamulin) in ...
2021-11-11 · Email Alerts; Nabriva Announces Availability of XENLETA® (lefamulin) in a 10-Count Oral Pack. Nabriva Announces Availability of XENLETA® (lefamulin) in a 10-Count Oral Pack . November 11, 2021 at 7:01 AM EST. 10-count oral pack – or ‘X’ pack allows for improved access and the opportunity to further expand retail availability. DUBLIN, Ireland and FORT …
Investors.nabriva.comNabriva Therapeutics | Company Email | Telephone | Contact ...
Contact details (email, telephone numbers etc.) for Nabriva Therapeutics
Pharmacompass.comnabriva
Reset password. Enter your username or email address and we'll email you instructions on how to reset your password
Nabriva.talentlms.comInvestor Relations | Nabriva Therapeutics
2018-01-10 · Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of novel antibiotics to treat serious infections. Nabriva Therapeutics has two products: Xenleta® (lefamulin), approved by the FDA in 2019 for both Oral and IV use, and CONTEPO (fosfomycin) for injection. The approval of CONTEPO has been impacted by FDA’s …
Investors.nabriva.comNabriva Corporate > About Nabriva > Our Products
© Nabriva Therapeutics plc, Ireland Registration No. 599588, 25-28 North Wall Quay, Dublin 1, Ireland
Nabriva.comNabriva Therapeutics Reports Inducement Grant Under Nasdaq ...
2 days ago · Nabriva Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Mar 01, 2022 - read this article along with other careers information, tips and advice on BioSpace Nabriva Therapeutics plc announced that it has granted a non-statutory stock option to purchase an aggregate of 12,000 ordinary shares of Nabriva Therapeutics as an …
Biospace.comStockNews.com Initiates Coverage on Nabriva Therapeutics ...
2022-03-03 · Nabriva Therapeutics has a fifty-two week low of $0.40 and a fifty-two week high of $2.33. In other Nabriva Therapeutics news, CEO Theodore R. Schroeder bought 100,000 shares of the firm's stock in a transaction that occurred on Tuesday, December 28th. The stock was bought at an average price of $0.57 per share, for a total transaction of ...
Marketbeat.comNabriva Therapeutics plc (NBRV) Stock Price, News, Quote ...
Nabriva Therapeutics Adjourns Extraordinary General Meeting of Shareholders on January 18, 2022. — Meeting to Reconvene on March 24, 2022 — DUBLIN, Ireland and FORT WASHINGTON, Pa., Jan. 18 ...
Finance.yahoo.comNabriva Therape Ads (NBRV-Q) Quote - Press Release - The ...
2001-07-22 · Nabriva Therapeutics to Report First Quarter 2021 Financial Results and Recent Corporate Highlights on May 6, 2021. GlobeNewswire - Fri Apr 30, 8:46AM CDT. Nabriva Therapeutics plc ( NASDAQ:NBRV ...
Theglobeandmail.comAdditional Proxy Soliciting Materials (definitive) (defa14a)
2022-01-14 · Nabriva Therapeutics Adjourns . Extraordinary General Meeting of Shareholders — Meeting to Reconvene on January 18, 2022 — DUBLIN, Ireland and FORT WASHINGTON, Pa., January 14, 2022 — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat …
Ih.advfn.comNabriva Therape Ads (NBRV-Q) Quote - Press Release - The ...
Nabriva Therapeutics Announces $25.4 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules. GlobeNewswire - Mon Mar 1, 7:00AM CST. Nabriva Therapeutics plc ( NASDAQ:NBRV ), a ...
Theglobeandmail.comNabriva Therape Ads (NBRV-Q) Quote - Press Release - The ...
Nabriva Therapeutics anticipates that subsequent events and developments will cause its views to change. However, while Nabriva Therapeutics may elect to update these forward-looking statements at ...
Theglobeandmail.comNBRV Nabriva Therapeutics — Stock Price and Discussion ...
2022-02-19 · NBRV Nabriva Therapeutics — Stock Price and Discussion | Stocktwits. Nabriva Therapeutics NASDAQ Updated Feb 19, 2022 12:20 AM. NBRV 0.51 0.02 (3.21%) Post-Market 0.01 (1.98%) 17,140. Key Data. 52wk Low 0.41.
Stocktwits.comTheodore R. Schroeder Net Worth, Biography & Insider ...
2021-12-28 · The corporate mailing address for Mr. Schroeder and other Nabriva Therapeutics executives is 25-28 NORTH WALL QUAY IFSC, DUBLIN L2, 19406. Nabriva Therapeutics can also be reached via phone at (531) 649-2000 and via email at [email protected]
Insidertrades.comAdditional Proxy Soliciting Materials (definitive) (defa14a)
2022-02-22 · Nabriva Therapeutics plc, an Irish public limited company (the “Company”) originally convened an extraordinary general meeting of its shareholders for December 22, 2021. However, this meeting was adjourned to March 24, 2022 to allow the Company to solicit from its shareholders the additional proxies necessary to obtain approval of the proposal described in …
Ih.advfn.comPETE WOLF, general counsel, nabriva therapeutics
Verify the professional email of PETE WOLF, general counsel, nabriva therapeutics. Email-verifier.io : the best email verifier in the world. Email-verifier.io. Back to homepage Email-Verifier.io is the BEST email verifier in the world. Test us for free! First Name: Pete ...
Directory.email-verifier.ioANDREW RANALLI, Corporate audit, nabriva therapeutics
Professional Email of Andrew Ranalli: [email protected] . Test the validity of this email address. Professional Email of Andrew Ranalli: [email protected] . Test the validity of this email address. Professional Email of Andrew Ranalli: [email protected] . Test the validity of this email address ...
Directory.email-verifier.ioNabriva Therapeutics Announces $25.4 Million Registered ...
2021-03-01 · About Nabriva Therapeutics plc Nabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections ...
Finance.yahoo.comNabriva Therape Ads (NBRV-Q) Press Releases - The Globe ...
2022-01-14 · Latest Press Releases for Nabriva Therape Ads (NBRV-Q). Skip to main content. Canada’s most-awarded newsroom for a reason . Enjoy unlimited digital access. $1.99. per …
Theglobeandmail.comXENLETA® (lefamulin) - WEP Clinical
Manufacturer: Nabriva Therapeutics U.S. INC. The XENLETA Named Patient Program is designed to ensure that physicians can request IV or oral XENLETA on behalf of patients who meet the necessary eligibility criteria and who live in certain countries where it is not yet available. If you would like to order XENLETA, please contact us using the email below: …
Wepclinical.com
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
amorganinteriors.com | srsplus.com | -1 Years, -344 Days |
crossroads4hope.org | whois.godaddy.com | -1 Years, -314 Days |
crystaldigest.com | namecheap.com | 88 Days |
firagran.com | dondominio.com | -1 Years, -208 Days |
kwk.us | domains.google | 343 Days |
kreweofjustinian.com | wildwestdomains.com | -2 Years, -56 Days |
preventis.com | ionos.com | -2 Years, -38 Days |
mag7raceseries.com | domain.com | 43 Days |
fvf-bff.org | openprovider.com | -2 Years, -180 Days |
evlear.com | one.com | -2 Years, -120 Days |